rs137853127
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001172509.2(SATB2):c.715C>T(p.Arg239*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001172509.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SATB2 | NM_001172509.2 | c.715C>T | p.Arg239* | stop_gained | Exon 7 of 11 | ENST00000417098.6 | NP_001165980.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1460450Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 726528
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Chromosome 2q32-q33 deletion syndrome Pathogenic:5Other:1
For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 2519). This premature translational stop signal has been observed in individuals with a clinical phenotype including cleft palate, intellectual disability and epilepsy (PMID: 17377962, 24301056). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg239*) in the SATB2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SATB2 are known to be pathogenic (PMID: 25885067). -
- -
- -
ACMG: PVS1, PS4_Moderate, PM2_Supporting -
- -
_x000D_ Criteria applied: PVS1, PS2, PS4_MOD, PS3_SUP, PM2_SUP -
not provided Pathogenic:4
- -
- -
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Published functional studies demonstrate an abnormal truncated protein that forms a dimer with wild-type SATB2 and interferes with the activity of the wild-type protein suggesting a dominant-negative mechanism (Leoyklang et al., 2007; Leoyklang et al., 2013); Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 24363063, 31209962, 31144778, 23925499, 17377962, 25525159, 27774744, 28787087, 24301056, 30848049, 31021519) -
- -
Cleft palate Pathogenic:1
- -
Intellectual disability Pathogenic:1
- -
SATB2-related disorder Pathogenic:1
The SATB2 c.715C>T variant is predicted to result in premature protein termination (p.Arg239*). This variant has been reported in individuals with SATB2-associated syndrome (for example Leoyklang et al. 2007. PubMed ID: 17377962; Zarate et al. 2019. PubMedID: 31021519). Functional studies revealed that this variant produces a truncated protein that dimerizes with the wild-type protein to act in a dominant negative mechanism (Leoyklang et al. 2007. PubMed ID: 17377962; Leoyklang et al. 2013. PubMed ID: 23925499). This variant has not been reported in a large population database, indicating this variant is rare. Nonsense variants in SATB2 are expected to be pathogenic. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at